Literature DB >> 19603201

Bisphosphonate-related osteonecrosis of the jaw: clinical correlations with computerized tomography presentation.

Sharon Elad1, Moshe J Gomori, Noa Ben-Ami, Silvina Friedlander-Barenboim, Eran Regev, Towy S Lazarovici, Noam Yarom.   

Abstract

The aim of this study was to correlate clinical and computerized tomography (CT) features of bisphosphonate-related osteonecrosis of the jaws (BRONJ). All ONJ patients for whom there was complete CT scan imaging were eligible. Selected clinical parameters retrieved from their medical records were analyzed for correlation with CT parameters. The clinical presentation of BRONJ was supported by findings in CT imaging in 78.3%. The lesion's size on CT correlated with the presence of purulent secretion (p = 0.03). When sequestrum was present, the median lesion's size on CT was relatively big (28 mm, range 21-43 mm). The mandibular canal cortex was never breached. CT has reasonable detection competence for diagnosing BRONJ. Purulent secretion indicates the likelihood that a more extensive involvement will be displayed on CT. A large lesion on CT should raise the index of suspicion for sequestrum. The CT appearance of a continuous cortex of the mandibular canal may serve as a differential parameter between BRONJ and metastasis to the jaw.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19603201     DOI: 10.1007/s00784-009-0311-3

Source DB:  PubMed          Journal:  Clin Oral Investig        ISSN: 1432-6981            Impact factor:   3.573


  20 in total

Review 1.  Bisphosphonate-associated osteonecrosis: a long-term complication of bisphosphonate treatment.

Authors:  Cesar A Migliorati; Michael A Siegel; Linda S Elting
Journal:  Lancet Oncol       Date:  2006-06       Impact factor: 41.316

2.  Jaw avascular bone necrosis associated with long-term use of biphosphonates.

Authors:  G Sanna; M G Zampino; G Pelosi; F Nolè; A Goldhirsch
Journal:  Ann Oncol       Date:  2005-04-22       Impact factor: 32.976

3.  Osteonecrosis of the jaw and bisphosphonates.

Authors:  Brian G M Durie; Michael Katz; John Crowley
Journal:  N Engl J Med       Date:  2005-07-07       Impact factor: 91.245

4.  Nature and frequency of bisphosphonate-associated osteonecrosis of the jaws in Australia.

Authors:  Tony Mavrokokki; Andrew Cheng; Brien Stein; Alastair Goss
Journal:  J Oral Maxillofac Surg       Date:  2007-03       Impact factor: 1.895

Review 5.  Narrative [corrected] review: bisphosphonates and osteonecrosis of the jaws.

Authors:  Sook-Bin Woo; John W Hellstein; John R Kalmar
Journal:  Ann Intern Med       Date:  2006-05-16       Impact factor: 25.391

Review 6.  Managing the care of patients with bisphosphonate-associated osteonecrosis: an American Academy of Oral Medicine position paper.

Authors:  Cesar A Migliorati; Jeffrey Casiglia; Joel Epstein; Peter L Jacobsen; Michael A Siegel; Sook-Bin Woo
Journal:  J Am Dent Assoc       Date:  2005-12       Impact factor: 3.634

7.  Osteonecrosis of the jaw in cancer after treatment with bisphosphonates: incidence and risk factors.

Authors:  Aristotle Bamias; Efstathios Kastritis; Christina Bamia; Lia A Moulopoulos; Ioannis Melakopoulos; George Bozas; Vassiliki Koutsoukou; Dimitra Gika; Athanasios Anagnostopoulos; Christos Papadimitriou; Evagelos Terpos; Meletios A Dimopoulos
Journal:  J Clin Oncol       Date:  2005-12-01       Impact factor: 44.544

8.  Osteonecrosis of the jaw in multiple myeloma patients: clinical features and risk factors.

Authors:  Ashraf Badros; Dianna Weikel; Andrew Salama; Olga Goloubeva; Abraham Schneider; Aaron Rapoport; Robert Fenton; Natalie Gahres; Edward Sausville; Robert Ord; Timothy Meiller
Journal:  J Clin Oncol       Date:  2006-02-20       Impact factor: 44.544

9.  Computerized tomographic findings in bisphosphonate-associated osteonecrosis of the jaw in patients with cancer.

Authors:  Silvio Diego Bianchi; Matteo Scoletta; Francesca Bozzalla Cassione; Giuseppe Migliaretti; Marco Mozzati
Journal:  Oral Surg Oral Med Oral Pathol Oral Radiol Endod       Date:  2007-06-07

10.  Frequency and risk factors associated with osteonecrosis of the jaw in cancer patients treated with intravenous bisphosphonates.

Authors:  Ana O Hoff; Béla B Toth; Kadri Altundag; Marcella M Johnson; Carla L Warneke; Mimi Hu; Ajay Nooka; Gilbert Sayegh; Valentina Guarneri; Kimberly Desrouleaux; Jeffrey Cui; Andrea Adamus; Robert F Gagel; Gabriel N Hortobagyi
Journal:  J Bone Miner Res       Date:  2008-06       Impact factor: 6.741

View more
  12 in total

1.  Bisphosphonate-associated osteonecrosis of the mandible: reliable soft tissue reconstruction using a local myofascial flap.

Authors:  Juliana Lemound; Andrè Eckardt; Horst Kokemüller; Constantin von See; Pit Jacob Voss; Frank Tavassol; Martin Rücker; Majeed Rana; Nils-Claudius Gellrich
Journal:  Clin Oral Investig       Date:  2011-08-05       Impact factor: 3.573

2.  Teriparatide and the treatment of bisphosphonate-related osteonecrosis of the jaw: a rat model.

Authors:  N Ersan; L J van Ruijven; A L J J Bronckers; V Olgaç; D Ilgüy; V Everts
Journal:  Dentomaxillofac Radiol       Date:  2013-10-29       Impact factor: 2.419

3.  Prevalence of radiographic findings on jaws exposed to antiresorptive therapy: a meta-analysis.

Authors:  Kamile Leonardi Dutra; Letícia Fernanda Haas; Glaucia S Zimmermann; Gilberto Melo; Mariana Comparotto Minamisako; Carlos Flores-Mir; Márcio Corrêa
Journal:  Dentomaxillofac Radiol       Date:  2018-11-07       Impact factor: 2.419

4.  Prevalence of bisphosphonate-associated osteonecrosis of the jaw after intravenous zoledronate infusions in patients with early breast cancer.

Authors:  Petra Rugani; Gero Luschin; Norbert Jakse; Barbara Kirnbauer; Uwe Lang; Stephan Acham
Journal:  Clin Oral Investig       Date:  2013-06-10       Impact factor: 3.573

5.  Influence of bisphosphonates on the osteoblast RANKL and OPG gene expression in vitro.

Authors:  Felix Peter Koch; Christina Merkel; Thomas Ziebart; Ralf Smeets; Christian Walter; Bilal Al-Nawas
Journal:  Clin Oral Investig       Date:  2010-10-12       Impact factor: 3.573

6.  Periapical disease and bisphosphonates induce osteonecrosis of the jaws in mice.

Authors:  Ben Kang; Simon Cheong; Thawinee Chaichanasakul; Olga Bezouglaia; Elisa Atti; Sarah M Dry; Flavia Q Pirih; Tara L Aghaloo; Sotirios Tetradis
Journal:  J Bone Miner Res       Date:  2013-07       Impact factor: 6.741

7.  Evaluation of BP-ONJ in osteopenic and healthy sheep: comparing ZTE-MRI with µCT.

Authors:  Pit Voss; Ute Ludwig; Philipp Poxleitner; Veronika Bergmaier; Nora El-Shafi; Dominik von Elverfeldt; Vincent Stadelmann; Jan-Bernd Hövener; Tabea Flügge
Journal:  Dentomaxillofac Radiol       Date:  2016-02-05       Impact factor: 2.419

8.  Imaging findings in bisphosphonate-induced osteonecrosis of the jaws.

Authors:  Katarina Surlan Popovic; Miha Kocar
Journal:  Radiol Oncol       Date:  2010-06-24       Impact factor: 2.991

9.  Oral bisphosphonate-related osteonecrosis of the jaws in rheumatoid arthritis patients: a critical discussion and two case reports.

Authors:  Nicolau Conte-Neto; Alliny S Bastos; Luis C Spolidorio; Rosemary Ac Marcantonio; Elcio Marcantonio
Journal:  Head Face Med       Date:  2011-04-27       Impact factor: 2.151

10.  Use and Evaluation of a Computer-Assisted Examination Method for the Diagnosis and Analysis of Medication-Related Osteonecrosis of the Jaw.

Authors:  Max Wilkat; Daman Deep Singh; Isabelle Lutz; Henriette Möllmann; Nils-Claudius Gellrich; Majeed Rana
Journal:  Craniomaxillofac Trauma Reconstr       Date:  2020-07-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.